Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,750 | 1 | 75.4% |
| Food and Beverage | $692.23 | 6 | 19.0% |
| Travel and Lodging | $204.76 | 1 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $3,160 | 4 | $0 (2022) |
| Acacia Pharma Inc | $239.62 | 2 | $0 (2021) |
| Merck Sharp & Dohme LLC | $124.72 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $123.05 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $225.44 | 2 | Merck Sharp & Dohme LLC ($124.72) |
| 2021 | $239.62 | 2 | Acacia Pharma Inc ($239.62) |
| 2019 | $227.17 | 2 | AstraZeneca Pharmaceuticals LP ($123.05) |
| 2018 | $2,955 | 2 | Pacira Pharmaceuticals Incorporated ($2,955) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2022 | Merck Sharp & Dohme LLC | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $124.72 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/28/2022 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $100.72 | General |
| Category: Pain Management | ||||||
| 11/11/2021 | Acacia Pharma Inc | BYFAVO (Drug) | Food and Beverage | In-kind items and services | $120.72 | General |
| Category: Anesthesiology | ||||||
| 07/07/2021 | Acacia Pharma Inc | BARHEMSYS (Drug) | Food and Beverage | In-kind items and services | $118.90 | General |
| Category: PONV postoperative nausea vomiting | ||||||
| 02/27/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Food and Beverage | In-kind items and services | $104.12 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/12/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/02/2018 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/01/2018 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Travel and Lodging | Cash or cash equivalent | $204.76 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 322 | 329 | $333,830 | $21,032 |
| 2022 | 10 | 382 | 392 | $312,230 | $22,380 |
| 2021 | 13 | 456 | 472 | $375,064 | $27,955 |
| 2020 | 11 | 324 | 332 | $271,990 | $21,189 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 29 | 29 | $24,530 | $1,719 | 7.0% |
| 00300 | Anesthesia for procedure on esophagus and neck | Office | 2021 | 17 | 17 | $22,550 | $1,624 | 7.2% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2021 | 25 | 25 | $19,470 | $1,569 | 8.1% |
| 01810 | Anesthesia for procedure on nerves, muscles, tendons, fascia, and bursae of forearm, wrist, and hand | Office | 2021 | 18 | 19 | $15,290 | $1,078 | 7.1% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 43 | 43 | $4,300 | $1,058 | 24.6% |
| 00140 | Anesthesia for procedure on eye | Office | 2021 | 11 | 11 | $11,330 | $826.74 | 7.3% |
| 00910 | Anesthesia for procedure on urinary system including use of an endoscope | Office | 2021 | 12 | 12 | $9,240 | $674.10 | 7.3% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Office | 2021 | 16 | 16 | $1,824 | $256.95 | 14.1% |
| 00142 | Anesthesia for lens surgery | Office | 2020 | 71 | 76 | $68,090 | $4,922 | 7.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2020 | 61 | 61 | $51,040 | $3,633 | 7.1% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 33 | 33 | $26,950 | $1,983 | 7.4% |
| 00300 | Anesthesia for procedure on esophagus and neck | Office | 2020 | 18 | 19 | $24,310 | $1,891 | 7.8% |
| 00103 | Anesthesia for procedure on eyelid | Office | 2020 | 15 | 15 | $16,940 | $1,545 | 9.1% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2020 | 19 | 19 | $20,130 | $1,484 | 7.4% |
| 01480 | Anesthesia for open procedure on bones of lower leg, ankle and foot | Office | 2020 | 11 | 11 | $14,410 | $1,314 | 9.1% |
| 01810 | Anesthesia for procedure on nerves, muscles, tendons, fascia, and bursae of forearm, wrist, and hand | Office | 2020 | 19 | 21 | $17,160 | $1,298 | 7.6% |
| 64415 | Injection of anesthetic agent and/or steroid into brachial nerve bundle of arm | Office | 2020 | 21 | 21 | $13,860 | $1,100 | 7.9% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2020 | 19 | 19 | $15,400 | $1,057 | 6.9% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 37 | 37 | $3,700 | $962.35 | 26.0% |
About Dr. Sandy Thammasithiboon, MD
Dr. Sandy Thammasithiboon, MD is a Anesthesiology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831390525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandy Thammasithiboon, MD has received a total of $3,647 in payments from pharmaceutical and medical device companies, with $225.44 received in 2022. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,750).
As a Medicare-enrolled provider, Thammasithiboon has provided services to 1,484 Medicare beneficiaries, totaling 1,525 services with total Medicare billing of $92,556. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Dallas, TX
- Active Since 05/30/2007
- Last Updated 06/29/2010
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1831390525
Products in Payments
- EXPAREL (Drug) $3,059
- RECARBRIO (Drug) $124.72
- FARXIGA (Drug) $123.05
- BYFAVO (Drug) $120.72
- BARHEMSYS (Drug) $118.90
- Exparel (Drug) $100.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Dallas
James Mueller, M.d, M.D
Anesthesiology — Payments: $753,569
Girish Joshi, Md, MD
Anesthesiology — Payments: $420,549
Dr. Peter Szmuk, Md, MD
Anesthesiology — Payments: $172,473
Dr. Richard Dutton, M.d, M.D
Anesthesiology — Payments: $89,445
Christina Riccio, M.d, M.D
Anesthesiology — Payments: $76,496
Dr. Michael Walsh, M.d, M.D
Anesthesiology — Payments: $65,832